David Peritt, Skokie, IL (US); Philip Wong, Cremorne (AU); Janet Lesley MacPherson, Leichhardt (AU); Kevin Henrichsen, Shamong, NJ (US); Geoffrey Phillip Symonds, Rose Bay (AU); and Susan Pond, Kirribilli (AU)
Assigned to Therakos Development Limited, Dublin (IE)
Filed by Therakos Development Limited, Dublin (IE)
Filed on Feb. 15, 2021, as Appl. No. 17/176,013.
Application 15/974,881 is a division of application No. 15/066,659, filed on Mar. 10, 2016, abandoned.
Application 17/176,013 is a continuation of application No. 16/171,096, filed on Oct. 25, 2018, granted, now 10,953,149.
Application 16/171,096 is a continuation of application No. 15/974,881, filed on May 9, 2018, granted, now 10,926,020, issued on Feb. 23, 2021.
Application 15/066,659 is a continuation of application No. 13/738,039, filed on Jan. 10, 2013, abandoned.
Application 13/738,039 is a continuation of application No. 12/628,303, filed on Dec. 1, 2009, abandoned.
Claims priority of provisional application 61/140,196, filed on Dec. 23, 2008.
Prior Publication US 2021/0187181 A1, Jun. 24, 2021
1. A method of processing blood, said method comprising the steps of: obtaining blood from a patient coupled to a single blood processing device to form a closed loop between said patient and said blood processing device; collecting bulk mononuclear blood cells from said blood by leukapheresis implemented using said blood processing device in said closed loop; and enriching concurrently target cells separated from non-target cells in said bulk mononuclear blood cells using said blood processing device in said closed loop.
